0

No products in the cart.

0

No products in the cart.

Home Business Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
Business

Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications

Updated 1 day Ago1 Mins read0 Views
Share
Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
Share


The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.

Source link

Share
Airbnb director Joseph Gebbia sells .5m in shares Previous post Airbnb director Joseph Gebbia sells $35.5m in shares

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Fitch affirms Turkmenistan at ’BB-’ on strong balance sheet
Business

Fitch affirms Turkmenistan at ’BB-’ on strong balance sheet

10 minutes Ago
Dürr H1 2026 slides: BBS overhaul weighs, guidance confirmed
Business

Dürr H1 2026 slides: BBS overhaul weighs, guidance confirmed

25 minutes Ago
This ‘intrinsic value’ small-cap stock strategy keeps benefiting from deep research
Business

This ‘intrinsic value’ small-cap stock strategy keeps benefiting from deep research

31 minutes Ago
Home Depot bull and bear case: rate sensitivity, pro-segment growth, and valuation
Business

Home Depot bull and bear case: rate sensitivity, pro-segment growth, and valuation

41 minutes Ago

Keep in touch

Subscribe to our newsletter to get our newest articles instantly!

    Copyright 2025. All rights reserved

    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com